What is a special purpose insurer?

Within the last six months the Guernsey Financial Services Commission (“Commission”) has published The Insurance Business (Special Purpose Insurer) Rules 2016 (“SPI Rules”), which clarify and confirm the regulatory definition and treatment of special purpose insurers (“SPIs”) under Guernsey law. The Insurance Business (Solvency) Rules 2015 (“Solvency Rules”) had already provided for Category 6 “Special Purpose Entities” as being primarily “insurers whose underwriting and counterparty risk are effectively eliminated” by being fully collateralised or fully funded. The Solvency Rules give examples of these as including:

1) Transformer cells, i.e. cells within a Guernsey Protected Cell Company whose primary purpose is to enable transactions between the Capital and Insurance markets by converting derivatives contracts into insurance contracts, or vice versa;

2) Fully collateralised catastrophe cells, i.e. cells within a Guernsey Cell Company which reinsure catastrophe risks and have 100% collateralisation through the issue of risk-linked securities to sophisticated investors; the collateral is subject to a trust or other security arrangement;

3) ILS cells – a broader category of 2. above, where the underlying insurance contracts are not limited to catastrophe risk; as well as natural catastrophes, ILS products typically cover life insurance (mortality and longevity) and man-made events (fire, terrorism, even lottery jackpot losses); and

4) Fully funded entities.

The SPI Rules have now provided a formal definition of “Special Purpose Insurer” as an insurer or cell which satisfies all of the following requirements:

The insurer or cell has at all times assets the value of which is equal to or exceeds its aggregate maximum risk exposure and the insurer or cell is able to pay the amounts it is liable for as they fall due;

The proceeds of the debt or equity issuance or other financing mechanism are fully paid in or in the form of contingent assets where the finance provider has achieved a financial rating (counterparty, credit or financial strength as applicable) of at least A- as of the date of application and as determined by an Acceptable Rating Agency;

Claims of participants in any financing mechanism against the assets of the insurer or the cell are subordinated to the claims of creditors under the contracts of insurance underwritten by the insurer or cell;

The insurer or cell only enters into contracts or otherwise assumes obligations or contingent liabilities which are solely necessary for it to give effect to the purposes set out from time to time in its agreed business plan; and

Each of the insurance contracts is structured so that the insurer or cell meets the fully funded requirements individually for each contract.

What are the benefits of domiciling in Guernsey?

Guernsey SPIs or other entities that the Commission agrees may fall into Category 6 (Special Purpose Entities) benefit from waivers of the regulatory capital and solvency requirements applicable to Guernsey insurers in other categories, so that they are not required to hold the minimum and prescribed capital under the Solvency Rules (Guernsey is outside of the EU and therefore not required to implement Solvency II). They can also benefit from a fast track self-certification approval process for creation and licensing of new cells. This process requires the manager of the SPI to self-certify the nature of the transactions contemplated and to provide the Commission with relevant documentation and the licensing fee within 7 days of the effective date of the insurance underwritten.

Other waivers include:

ILS SPVs can benefit from a waiver from the requirement for accounts to comply fully with UK GAAP FRS in relation to notes to FRS accounts;

Certain long term SPVs, for example runoff situations or reinsurance of pension scheme longevity risk, may benefit from a waiver of the requirement for an appointed actuary (normally required for long term business).

These benefits are in addition to the normal benefits of establishing an insurer in Guernsey, including a tax neutral environment and appropriate, high quality regulation to recognised international standards.

Share
Twitter LinkedIn Email Save as PDF
More Publications
30 Jul 2021 |

Fighting international fraud

First published in New Law Journal, July 2021. Appleby partners Anthony William and Jared Dann an...

Contributors: Jared Dann, Claire Corkish
20 May 2021 |

The Gender Pay Gap Debate – a response to comments on social media

As a lawyer the majority of articles we write are about a particular case or a legal issue – which...

4 May 2021 |

New Private Investment Funds in Guernsey

In December 2020, the Guernsey Financial Services Commission (Commission) published a consultation p...

Contributors: Oratile Jonas
16 Mar 2021 |

Guernsey Structures - The Cannabis Investment Conundrum

Jurisdictions around the world have adopted different positions in relation to the legality of the c...

12 Mar 2021 |

Material adverse change clauses in light of the Covid-19 pandemic

Experts from each of our key global offices provide jurisdiction specific advice and answer question...

8 Mar 2021 |

Appleby Celebrates International Women’s Day

International Women’s Day is celebrated annually in support of gender equality and equal participa...

23 Feb 2021 |

Fit and Proper in the Channel Islands – A Regulatory Enforcement Update

It is sometimes easy to forget with all that has happened over the last 12 months that there was a w...

27 Jan 2021 |

Levies, registration and all that jazz

Regulatory markets evolve at various speeds and the data protection regime is one example of a marke...

6 Jan 2021 |

Executors navigating the “perfect (company) storm”

Corporate governance has become one of the most hotly debated topics in recent years. Whether it be ...

Contributors: Paula Fry